The Latest Breaking News from Amylyx Pharma

Steve Cohen's Point72 Goes Heavy on Tech and Pharma Stocks, Investing Over $330M in Two Trades

Point72 Asset Management recently purchased over 10 million shares of Confluent and Amylyx Pharma common stock, worth more than $334.17 million.

International Business Times UK · Jun 26, 2025

4 Analysts Assess Amylyx Pharma: What You Need To Know

During the last three months, 4 analysts shared their evaluations of Amylyx Pharma (NASDAQ:AMLX), revealing diverse outlooks from bullish to bearish.

Benzinga · Dec 5, 2024

What 4 Analyst Ratings Have To Say About Amylyx Pharma

Within the last quarter, Amylyx Pharma (NASDAQ:AMLX) has observed the following analyst ratings:

Benzinga · Jun 14, 2022